Showing results (41-50 of 993) with videos related to
Sort By:
Pageof 100
Drugs|May 20, 2026
Recent Developments in the Drug Treatment of Parkinson's DiseaseSimon Leiter, Philipp Mahlknecht, Werner PoeweCurrent Opinion in Neurology|May 18, 2011
New insights into atypical parkinsonismGregor K Wenning, Florian Krismer, Werner PoeweExperimental Neurology|January 29, 2008
Rasagiline is neuroprotective in a transgenic model of multiple system atrophyNadia Stefanova, Werner Poewe, Gregor K WenningMovement Disorders : Official Journal of the Movement Disorder Society|August 23, 2018
Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging FeaturesK Ray Chaudhuri, Werner Poewe, David BrooksClinical Interventions in Aging|April 14, 2012
Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's diseaseEva-Maria Hametner, Klaus Seppi, Werner PoeweMovement Disorders : Official Journal of the Movement Disorder Society|August 11, 2005
Therapeutic strategies in multiple system atrophyGregor K Wenning, Felix Geser, Werner PoeweExpert Opinion on Drug Safety|April 4, 2012
Drug safety evaluation of rotigotineFabienne Stephanie Sprenger, Klaus Seppi, Werner PoeweExpert Review of Neurotherapeutics|August 26, 2011
Pramipexole extended release in Parkinson's diseaseEva-Maria Hametner, Klaus Seppi, Werner PoeweMovement Disorders : Official Journal of the Movement Disorder Society|December 30, 2014
Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRSWerner Poewe, Robert A Hauser, Anthony Lang, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|November 17, 2010
Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's diseaseNir Giladi, Andreas Fichtner, Werner Poewe, et al.Pageof 100